Diacerein Loaded Novasome for Transdermal Delivery: Prepartion , In-Vitro Characterization and Factors Affecting Formulation
DOI:
https://doi.org/10.31351/vol32issSuppl.pp214-224Abstract
Diacerein (DCN) is a semi-synthetic anthraquinone derivative of Rhein that is indicated for the management of osteoarthritis. Diacerein exhibits poor dissolution in the GIT fluids and suffers from low bioavailability upon oral administration in addition to the laxative effect of Rhein metabolites. The aim of the present study was to develop novasomal vesicles with optimized entrapment efficiency and size to serve as a carrier for transdermal delivery of diacerein. Novasomal vesicles were prepared by thin film hydration method thin film hydration. The prepared vesicles were optimized utilizing different surfactant to cholesterol molar ration, sonication type, different sonication times and varying fatty acid level. The prepared vesicles were characterized for drug entrapment efficiency, vesicle size and PDI. The best formula was further investigated for zeta potential ten TEM and compatibility study by FTIR analysis. Results showed that F6 was the best formula regarding it vesicle size 275.2± 2.68nm , entrapment efficiency 69.415± 0.234 % and PDI 0.309± 0.016. In conclusion , novasomal dispersion could be successfully formulated with thin film hydration method.
Keywords: Diacerein , Novasome , Transdermal Delivery ,Vesicular System .
How to Cite
Publication Dates
References
Patel V, Joharapurkar A, Jain M. Therapeutic Potential of Diacerein in Management of Pain. Current Drug Research Reviews Formerly: Current Drug Abuse Reviews. 2022 Nov 1;14(3):215-224
Fouad SA, Malaak FA, El-Nabarawi MA, Abu Zeid K, Ghoneim AM. Preparation of solid dispersion systems for enhanced dissolution of poorly water soluble diacerein: In-vitro evaluation, optimization and physiologically based pharmacokinetic modeling. PLoS One. 2021 Jan 20;16(1).
Eladawy NO, Morsi NM, Shamma RN. Diacerein-loaded hyaluosomes as a dual-function platform for osteoarthritis management via intra-articular injection: in vitro characterization and in vivo assessment in a rat model. Pharmaceutics. 2021 May 21;13(6):765.
Shabbir M, Barkat K, Ashraf MU, Nagra U, Shah SN. Assessment of formulation variables of poor water soluble diacerein for its improved loading and anti-inflammatory activity. Drug Delivery and Translational Research. 2023 Feb 3:1-9.
El-Laithy HM, Basalious EB, El-Hoseiny BM, Adel MM. Novel self-nanoemulsifying self-nanosuspension (SNESNS) for enhancing oral bioavailability of diacerein: simultaneous portal blood absorption and lymphatic delivery. International journal of pharmaceutics. 2015 Jul 25;490(1-2):146-54.
Panova E, Jones G. Benefit–risk assessment of diacerein in the treatment of osteoarthritis. Drug safety. 2015 Mar;38:245-52.
Chattopadhyay H, Datta S. Transdermal delivery of diacerein with homing carrier glucosamine sulphate laden in oil-in-water nanoemulsion. Materials Today: Proceedings. 2018 Jan 1;5(3):9690-9697.
Shabbir M, Barkat K, Ashraf MU, Nagra U. Development of a Novel Self-Dissolving Microneedle-Assisted Percutaneous Delivery System of Diacerein through Solid Dispersion Gel: Solubility Enhancement, Proof of Anti-inflammatory Activity and Safety. Current Drug Delivery. 2023.
Benson HA, Grice JE, Mohammed Y, Namjoshi S, Roberts MS. Topical and transdermal drug delivery: from simple potions to smart technologies. Current drug delivery. 2019 Jun 1;16(5):444-460.
Aggarwal AK, Singh S. Fast-Dissolving and High-Drug-Loaded, Fatty Acid–Based Self-Emulsifying Solid Dispersions of Diacerein. PDA Journal of Pharmaceutical Science and Technology. 2012 May 1;66(3):201-13.
Richard C, Cassel S, Blanzat M. Vesicular systems for dermal and transdermal drug delivery. RSC advances. 2021;11(1):442-451.
Mirtaleb MS, Shahraky MK, Ekrami E, Mirtaleb A. Advances in biological nano-phospholipid vesicles for transdermal delivery: A review on applications. Journal of Drug Delivery Science and Technology. 2021 Feb 1;61:102331.
Ahmed S, Amin MM, Sayed S. A comprehensive review on recent nanosystems for enhancing antifungal activity of fenticonazole nitrate from different routes of administration. Drug Delivery. 2023 Dec 31;30(1):2179129.
Chacko IA, Ghate VM, Dsouza L, Lewis SA. Lipid vesicles: A versatile drug delivery platform for dermal and transdermal applications. Colloids and Surfaces B: Biointerfaces. 2020 Nov 1;195:111262.
Atef B, Ishak RA, Badawy SS, Osman R. Exploring the potential of oleic acid in nanotechnology-mediated dermal drug delivery: An up-to-date review. Journal of Drug Delivery Science and Technology. 2022 Jan 1;67:103032.
Qadir A, Gupta DK, Mir Najib Ullah SN, Aqil M, Jahan S, Khan N. Pinpoint and Stewardship of Psoriasis by Using Phytoconstituent-based Novel Formulation. Current Bioactive Compounds. 2023 May 1;19(4):12-30.
Aziz DE, Abdelbary AA, Elassasy AI. Investigating superiority of novel bilosomes over niosomes in the transdermal delivery of diacerein: in vitro characterization, ex vivo permeation and in vivo skin deposition study. Journal of liposome research. 2019 Jan 2;29(1):73-85.
Zainab A. Sadeq . Microneedle Array Patches:Characterization and in-vitro Evaluation. Iraqi Journal of Pharmaceutical Sciences . 2021 June 15;30(1):66-75.
Alwan RM, Rajab NA. Nanosuspensions of Selexipag: Formulation, Characterization, and in vitro Evaluation. Iraqi Journal of Pharmaceutical Sciences. 2021 Jun 15;30(1):144-53.
Ala’a DN, Rajab NA. Formulation and characterization of niosomes for controlled delivery of tolmetin. Journal of Pharmaceutical Negative Results. 2022 Oct 7;13(4):159-169.
Abed HN, Hussein AA. Ex-vivo absorption study of a novel dabigatran etexilate loaded nanostructured lipid carrier using non-everted intestinal SAC model. Iraqi J Pharm Sci. 2019;28(2):37-45.
Thamer AK, Abood AN. Preparation and In vitro Characterization of Aceclofenac Nanosuspension (ACNS) for Enhancement of Percutaneous Absorption using Hydrogel Dosage Form. Iraqi Journal of Pharmaceutical Sciences. 2021 Dec 9;30(2):86-98.
Noor AH, Ghareeb MM. Transdermal Dissolvable Microneedle-mediated Delivery of Controlled Release Ondansetron Hydrogen Chloride Nanoparticles. IJDDT. 2021;11:858-863.
Abdulbaqi MR, Rajab NA. Preparation, characterization and ex vivo permeability study of transdermal apixaban O/W nanoemulsion based gel. Iraqi Journal of Pharmaceutical Sciences. 2020 Dec 30;29(2):214-22.
Basha, M., et al., Design and optimization of surfactant-based nanovesicles for ocular delivery of Clotrimazole. J Liposome Res, 2013. 23(3): p.203-210
M. R. Silverstein, In Spectrometric Identification of Organic Compounds, John Wiley & Sons In, New York, (2005).
Alkawak RS, Rajab NA. Lornoxicam-Loaded Cubosomes:-Preparation and In vitro Characterization. Iraqi Journal of Pharmaceutical Sciences. 2022 Jun 17;31(1):144-153.
El-Nabarawi MA, Shamma RN, Farouk F, Nasralla SM. Bilosomes as a novel carrier for the cutaneous delivery for dapsone as a potential treatment of acne: preparation, characterization and in vivo skin deposition assay. Journal of liposome research. 2020 Jan 2;30(1):1-1.
Tawfik MA, Mohamed MI, Tadros MI, El-Helaly SN. Low-frequency sonophoresis as an active approach to potentiate the transdermal delivery of agomelatine-loaded novasomes: design, optimization, and pharmacokinetic profiling in rabbits. AAPS PharmSciTech. 2021 Nov;22:1-5.
Witika BA, Bassey KE, Demana PH, Siwe-Noundou X, Poka MS. Current advances in specialised niosomal drug delivery: Manufacture, characterization and drug delivery applications. International Journal of Molecular Sciences. 2022 Aug 26;23(17):9668.
Karim, K.; Mandal, A.; Biswas, N.; Guha, A.; Chatterjee, S.; Behera, M.; Kuotsu, K. Niosome: A future of targeted drug delivery systems. J. Adv. Pharm. Technol. Res. 2010, 1, 374–380.
Richardson ES, Pitt WG, Woodbury DJ. The role of cavitation in liposome formation. Biophys J 2007;12:4100-4107.
Owodeha-Ashaka K, Ilomuanya MO, Iyire A. Evaluation of sonication on stability-indicating properties of optimized pilocarpine hydrochloride-loaded niosomes in ocular drug delivery. Progress in Biomaterials. 2021 Sep;10:207-220.
Nowroozi F, Almasi A, Javidi J, Haeri A, Dadashzadeh S. Effect of surfactant type, cholesterol content and various downsizing methods on the particle size of niosomes. Iranian journal of pharmaceutical Research: IJPR. 2018;17(Suppl2):1
Hashim AA, Rajab NA. Anastrozole Loaded Nanostructured Lipid Carriers: Preparation and Evaluation. Iraqi Journal of Pharmaceutical Sciences. 2021 Dec 11;30(2):185-195.
Essa EA. Effect of formulation and processing variables on the particle size of sorbitan monopalmitate niosomes. Asian Journal of Pharmaceutics. 2010;4(4).
Al-Mahallawi AM, Abdelbary AA, Aburahma MH. Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam. International journal of pharmaceutics. 2015 May 15;485(1-2):329-240.
Thomas, L. and V. Viswanad, Formulation and optimization of clotrimazole-loaded proniosomal gel using 3(2) factorial design. Sci Pharm, 2012. 80(3): p. 731-748.
Rajendran V. Effect of niosomes in the transdermal delivery of antidepressant sertraline hydrochloride. Journal of Scientific and Innovative Research. 2016;5(4):138 - 148.
Mokhtar, M., et al., Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm, 2008. 361(1-2): p. 104- 111.
Sezgin-Bayindir Z, Yuksel N. Investigation of formulation variables and excipient interaction on the production of niosomes. Aaps Pharmscitech. 2012 Sep;13:826-35.
Hajare AA, Dol HS. Screening of effective formulation techniques for Designing and Fabrication of Terbinafine hydrochloride ethosomes. Research Journal of Pharmacy and Technology. 2021;14(3):1353-1359.
Yeo LK, Chaw CS, Elkordy AA. The effects of hydration parameters and co-surfactants on methylene blue-loaded niosomes prepared by the thin film hydration method. Pharmaceuticals. 2019 Mar 29;12(2):46.
Muller, R.H.; Jacobs, C.; Kayser, O. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv. Drug Deliv. Rev., 2001, 47(1), 3-19.
Allam AN, Hamdallah SI, Abdallah OY. Chitosan-coated diacerein nanosuspensions as a platform for enhancing bioavailability and lowering side effects: preparation, characterization, and ex vivo/in vivo evaluation. International journal of nanomedicine. 2017;12:4733.
Mosallam S, Ragaie MH, Moftah NH, Elshafeey AH, Abdelbary AA. Use of novasomes as a vesicular carrier for improving the topical delivery of terconazole: in vitro characterization, in vivo assessment and exploratory clinical experimentation. International Journal of Nanomedicine. 2021;16:119.
Aggarwal AK, Singh S. Physicochemical characterization and dissolution study of solid dispersions of diacerein with polyethylene glycol 6000. Drug development and industrial pharmacy. 2011; 37 (10):1181–1191.
Khan MI, Madni A, Peltonen L. Development and in-vitro characterization of sorbitan monolaurate and poloxamer 184 based niosomes for oral delivery of diacerein. European Journal of Pharmaceutical Sciences. 2016; 95:88–95.
Khan MI, Madni A, Ahmad S, Mahmood MA, Rehman M, Ashfaq M. Formulation design and characterization of a non-ionic surfactant based vesicular system for the sustained delivery of a new chondroprotective agent. Brazilian Journal of Pharmaceutical Sciences. 2015 Jul;51:607-615.
Shah H, Madni A, Rahim MA, Jan N, Khan A, Khan S, Jabar A, Ali A. Fabrication, in vitro and ex vivo evaluation of proliposomes and liposomal derived gel for enhanced solubility and permeability of diacerein. Plos one. 2021 Oct 19;16(1
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Iraqi Journal of Pharmaceutical Sciences ( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512)
This work is licensed under a Creative Commons Attribution 4.0 International License.
